Microbiome 80B: The Next Generation High-Potency Probiotic

In this article, Dr. Adam Livingston PharmD explores the evolution of the NutriChem probiotic line and the research behind our latest probiotics Microbiome 80B.
Written by: DR. ADAM LIVINGSTON, PHARMD
  • Home
  • Blog
  • Microbiome 80B: The Next Generation High-Potency Probiotic

NutriChem has always been a pioneer in the realm of probiotic supplements.

Almost 30 years ago, Kent MacLeod, clinical pharmacist, NutriChem’s founder and CEO, put together a simple but highly effective probiotic blend that blew up in the city of Ottawa, known as Nutridophilus.

What is Nutridophilus?

Nutridophilus is a combination of Lactobacillus probiotic bacterial strains naturally found in the human digestive tract. All the bacteria in Nutridophilus, known as Lactobacillus, produce lactic acid (hence their name) and are friendly bacteria that help to maintain the digestive tract’s microbial population, known as the gut microbiome.

The beauty of Nutridophilus is that it is dairy-free, gluten-free, shelf-stable at room temperature, it helps to maintain healthy bacteria in the human digestive tract, and it can provide a gentle gut-soothing effect quickly as well.

Nutridophilus contains 4 clinically tested lactobacillus strains of probiotic bacteria: Lactobacillus casei, Lactobacillus helveticus, Lactobacillus plantarum and Lactobacillus rhamnosus. For decades, this simple but effective probiotic helped many NutriChem clients to relieve digestive problems and maintain their gut microbiomes.

Emerging Research

As an explosion of probiotic research emerged in the late 1990s and early 2000s, many newer-age probiotics started to enter the probiotic market, adding a keystone probiotic group to natural health products – Bifidobacterium. These newer probiotics conferred even more benefit to patients seeking digestive relief when they combined the well-established Lactobacteria strains with the newer-developed Bifidobacteria strains. This led to even more benefits than either individual group of probiotics (Mills et al 2023).

Microbiome 80B

Right on cue, to keep up with the times and the cutting edge of natural health products, NutriChem developed Microbiome 80B, a new-age probiotic that contains very similar Lactobacillus strains to Nutridophilus, as well as 5 clinically tested Bifidobacterium strains: Bifidobacterium Lactis, Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Infantis, Bifidobacterium Bifidum.

Bifidobacterium needs to be refrigerated for stability purposes, which can be inconvenient, but combining the Lactobacillus and Bifidobacterium groups together offers a stacked probiotic benefit. Bifidobacteria probiotics are associated with many health benefits. For example, several bifidobacteria strains have shown to significantly reduce symptoms of inflammatory bowel disease (Saez-Lara M. 2015), and taking specific strains like Bifidobacterium Breve has been associated with lower body fat composition (Sung et al. 2023).

As a clinical pharmacist, I often recommend Microbiome 80B as a great probiotic to replenish probiotic bacteria after a course of antibiotics. It contains 80 billion units of bacteria per capsule, which is on the higher end of probiotic potency, but it is still gentle with minimal side effects. I also recommend Microbiome 80B as a daily multi-probiotic for the maintenance of healthy gut bacteria and overall health.

If you are interested in probiotics, or you want to speak with a healthcare professional about improving your gut health, come into NutriChem today!

References

Mills S, Yang B, Smith GJ, Stanton C, Ross RP. Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond. Gut Microbes. 2023 Jan-Dec;15(1):2186098. doi: 10.1080/19490976.2023.2186098. PMID: 36896934; PMCID: PMC10012958.

Saez-Lara M, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. 2015;2015:505878. doi: 10.1155/2015/505878. Epub 2015 Feb 22. PMID: 25793197; PMCID: PMC4352483.

Sung, H, Youn, S, Choi, Y, Eun, S., & Shin, S. (2023). Body Fat Reduction Effect of Bifidobacterium breve B-3: A Randomized, Double-Blind, Placebo Comparative Clinical Trial. Nutrients, 15(1), 28. https://doi.org/10.3390/nu15010028

Share this blog post:
Facebook
Twitter
LinkedIn
Email
Dr.Adam Livingston in Pharmacy
DR. ADAM LIVINGSTON, PHARMD

Adam is a licensed pharmacist and NutriChem’s Deprescribing Program Coordinator. He completed his undergraduate degree in Biochemistry at Queen’s University before attending The University of Toronto, where he graduated as a Doctor of Pharmacy in 2017. As a pharmacist, Adam is a proponent of the appropriate use of medications. However, he is also passionate about providing patients with evidence-based options, whether these are prescription drugs or natural alternatives where appropriate.

By combining pharmacological and natural approaches to patients’ treatment regimens, Adam aims to maximize patient outcomes, not just dispense more prescription drugs. His professional interests include deprescribing, digestive health, mental health, and addiction. If you have had poor results with your prescription medications, come in to NutriChem and have a chat with Adam today!